Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer Center, University of Maryland Greenebaum Comprehensive Cancer Center, Karmanos Cancer Center, and Regions Hospital Cancer Care Center.
Dr. Dudek is a medical oncologist at Regions Hospital Cancer Care Center in St. Paul, Minnesota, an investigator at HealthPartners Institute, and a professor in the Department of Medicine at University of Minnesota.
Watch MesoTV
MesoTV and all of its informational videos are possible with the generous support of our donors and sponsors. Importantly, during this difficult time we are able to continue serving, informing, and educating the mesothelioma community. Please take note of our Season 2 sponsors at the beginning of the video: Merck; The Gori Law Firm; and Early, Lucarelli, Sweeney & Meisenkothen.
Don’t miss any of our new videos – sign up to receive our news or subscribe to our YouTube Channel by pressing the red “Subscribe” button.
MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.
